Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)

US10214592B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10214592-B2
Application numberUS-201515505762-A
CountryUS
Kind codeB2
Filing dateAug 7, 2015
Priority dateAug 22, 2014
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The purpose of the present invention is to provide a monoclonal antibody that is useful in specifically assaying tartrate resistant acid phosphatase 5b (TRACP-5b). A hybridoma producing a monoclonal antibody against TRACP-5b, said monoclonal antibody showing higher reactivity with TRACP-5b than with tartrate resistant acid phosphatase 5a (TRACP-5a) and, therefore, being specific to TRACP-5b, is obtained by cell fusion using, as an antigen, human recombinant TRACP-5b purified from silkworm silk gland. By using this monoclonal antibody, TRACP-5b in a specimen can be highly sensitively and specifically detected.

First claim

Opening claim text (preview).

The invention claimed is: 1. A monoclonal antibody which recognizes an epitope based on a steric structure of TRACP-5b (Tartrate-Resistant Acid Phosphatase 5b); which does not recognize any of epitopes formed of a primary structure of linear sequence of TRACP-5b; and which does not bind to TRACP-5a (Tartrate-Resistant Acid Phosphatase 5a), wherein said antibody is produced by Hybridoma TrK-126 of Accession number NITE BP-01866 or Hybridoma TrK-127 of Accession number NITE BP-01867. 2. Hybridoma TrK-126 of Accession number NITE BP-01866. 3. Hybridoma TrK-127 of Accession number NITE BP-01867. 4. A kit for use in detection of TRACP-5b (Tartrate-Resistant Acid Phosphatase 5b), comprising the monoclonal antibody produced by Hybridoma TrK-126 of Accession number NITE BP-01866 and the monoclonal antibody produced by Hybridoma TrK-127 of Accession number NITE BP-01867; wherein each of these monoclonal antibodies recognizes an epi tope based on a steric structure of TRACP-5b; does not recognize any of epitopes formed of a primary structure of linear sequence of TRACP-5b; and does not bind to TRACP-5a (Tartrate-Resistant Acid Phosphatase 5a), as constituents.

Assignees

Inventors

Classifications

  • Immunoassay; Biospecific binding assay; Materials therefor · CPC title

  • involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)} · CPC title

  • Synthetic resin · CPC title

  • from tumour cells · CPC title

  • Fused cells, e.g. hybridomas · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10214592B2 cover?
The purpose of the present invention is to provide a monoclonal antibody that is useful in specifically assaying tartrate resistant acid phosphatase 5b (TRACP-5b). A hybridoma producing a monoclonal antibody against TRACP-5b, said monoclonal antibody showing higher reactivity with TRACP-5b than with tartrate resistant acid phosphatase 5a (TRACP-5a) and, therefore, being specific to TRACP-5b, is…
Who is the assignee on this patent?
Nitto Boseki Co Ltd
What technology area does this patent fall under?
Primary CPC classification G01N33/543. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).